Glaukos Corporation Announces Third Quarter 2015 Financial Results
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced financial results for the third quarter ended September 30, 2015. Key highlights of the quarter, compared to the same period in 2014, include: Achieved 57% growth in net sales to $19.0 million, compared to $12.1 million Expanded gr
